STANDARD BIOTOOLS INC. — Director's Dealing 2016

Nov 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2016-11-08

Reporting Person: Linthwaite Stephen Christopher (President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-08	Employee Stock Option (Right to Buy)	$4.99	A	140000	Acquired	2026-11-08	Common Stock (140000.0)	Direct

Footnotes

F1: 12/48th of the total number of shares subject to the Option will vest and become exercisable on October 19, 2017 and 1/48th of the total number of shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that all shares subject to the Option will be fully vested and exercisable on October 19, 2020, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.